Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
2-Imino 2H-Chromene and 2-(Phenylimino) 2H-Chromene 3-Aryl Carboxamide Derivatives As Novel Cytotoxic Agents: Synthesis, Biological Assay, and Molecular Docking Study Publisher



Edraki N1 ; Iraji A1 ; Firuzi O1 ; Fattahi Y2 ; Mahdavi M2 ; Foroumadi A2 ; Khoshneviszadeh M1 ; Shafiee A2 ; Miri R1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  2. 2. Department of Medicinal Chemistry, Faculty of Pharmacy, and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of the Iranian Chemical Society Published:2016


Abstract

The inhibition of AKR1B10 has been recognized as a potential therapeutic approach to the treatment of various types of cancers. A novel series of compounds with imino-2H-chromen and phenylimino-2H-chromen scaffolds were synthesized by Knoevenagel condensation reaction. The in vitro cytotoxic activity of synthesized compounds was evaluated against MOLT-4 and SK-OV-3 cells. Among the tested compounds, N-(3,4-dimethoxyphenyl)-2-(phenylimino)-2H-chromene-3-carboxamide (8g) demonstrated potent inhibitory activity against both examined cell lines. The results of the molecular docking study suggested that this compound is involved in critical hydrogen-bonding interactions with the Val301 and Lue302 of AKR1B10 catalytic site. © 2016, Iranian Chemical Society.